Horse chestnut, derived from the seeds of Aesculus hippocastanum, has a long history of traditional use in Europe and has been the subject of considerable modern research. The primary active compound, aescin, is what most standardized extracts are built around. Studies indicate that horse chestnut seed extract may support healthy blood circulation and help reduce swelling associated with chronic venous insufficiency, a condition involving poor blood flow in the legs. Research also suggests potential benefits for easing mild inflammation, reducing fluid retention, and providing comfort related to hemorrhoids, likely through its effects on vein tone and capillary permeability. While findings are promising, particularly for leg vein health, ongoing research continues to clarify the full scope of its benefits and long-term safety profile.
Compare this supplementResearch suggests that horse chestnut seed extract, particularly its active compound escin, shows meaningful promise ...
View studies →Research suggests that horse chestnut and its primary active compound escin (also called aescin) demonstrate meaningf...
View studies →Research suggests that horse chestnut extract may support vascular health and blood circulation, with early mid-20th ...
View studies →Research suggests that horse chestnut may offer some benefit for hemorrhoid relief, with studies pointing to its anti...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 300 mg | Twice daily | hemorrhoid relief, venous tone support | Standardized extract (16-21% escin) used in clinical studies on hemorrhoids and venous health |
| Extract | 300–600 mg | Twice daily | chronic venous insufficiency, edema reduction, blood circulation | Standardized to 50mg escin per dose; well-established in multiple RCTs for CVI |
| Extract | 50–100 mg | Twice daily | edema reduction, anti-inflammatory (dosed as escin content) | Escin-standardized dosing used in clinical trials; 50mg escin twice daily is most common |
| Topical | 2 % | Twice daily | localized edema, bruising, anti-inflammatory | 2% escin gel used in clinical research for topical anti-inflammatory and edema applications |